Epigral Limited: Empowering Transparency and Shareholder Confidence

Epigral Limited: Explore Epigral Limited’s upcoming board meeting, regulatory compliance, and its impact on shareholder confidence.

Introduction: Epigral Limited:

Epigral Limited, formerly known as ‘Meghmani Finechem Limited,’ has recently made significant strides in its corporate journey. One such milestone is the forthcoming board meeting scheduled for Monday, 22nd April 2024. This article delves into the intricacies of the meeting, the regulatory obligations, and the implications for stakeholders.

Name Change and Regulatory Disclosure

The transformation from Meghmani Finechem Limited to Epigral Limited marks a strategic decision aimed at aligning the company’s brand identity with its evolving vision and objectives. Such changes necessitate compliance with regulatory norms, particularly concerning disclosure requirements mandated by SEBI (Securities and Exchange Board of India).

also read: Aurionpro Solutions Limited: Fundraising Announcement Overview

Details of the Board Meeting

The upcoming board meeting holds paramount importance for stakeholders. Scheduled to convene at the Epigral Tower in Ahmedabad, the agenda includes crucial matters such as:

Date and Venue

The meeting is slated for Monday, 22nd April 2024, at Epigral Tower, located at B/h Safal Profitaire, Corporate Road, Prahladnagar, Ahmedabad – 380 015.

Agenda Items

Audited Financial Results

The board will review the audited financial results for the quarter and fiscal year ending 31st March 2024. This comprehensive evaluation is pivotal for assessing the company’s performance and financial health.

Final Dividend Recommendation

Another significant agenda item is the recommendation of the final dividend, if any, on the equity shares of Rs. 10/- each for the financial year concluded on 31st March 2024. This decision holds implications for shareholders and reflects the company’s commitment to value creation.

Any Other Business

Additionally, the board may address other pertinent matters with the permission of the chair, ensuring comprehensive governance and decision-making.

Importance of Audited Financial Results

Audited financial results serve as a cornerstone of transparency and accountability in corporate governance. They provide stakeholders, including investors, analysts, and regulatory bodies, with vital insights into the company’s financial performance, risk management practices, and adherence to regulatory standards.

Significance of Final Dividend Recommendation

The recommendation of a final dividend underscores the company’s commitment to shareholder value. By distributing profits to shareholders, Epigral Limited not only rewards their investment but also signals financial stability and confidence in future prospects.

Shareholder Information

The intimation of the board meeting serves as a means to keep shareholders informed and engaged in corporate affairs. It empowers them to participate in decision-making processes and reinforces transparency and trust between the company and its investors.

Conclusion

In conclusion, Epigral Limited’s upcoming board meeting represents a significant juncture in its corporate journey. By adhering to regulatory obligations and prioritizing transparency, the company reaffirms its commitment to shareholder interests and sustainable growth.

FAQs

1. What is the significance of the name change from Meghmani Finechem Limited to Epigral Limited?
   • The name change reflects the company’s strategic realignment and rebranding efforts to better align with its vision and objectives.
2. How do audited financial results impact shareholder confidence?
   • Audited financial results provide stakeholders with reliable insights into the company’s financial performance, fostering transparency and bolstering investor confidence.
3. Can shareholders attend the board meeting?
   • Typically, board meetings are convened for members of the board of directors; however, shareholders may be provided opportunities to attend or receive updates on meeting proceedings.
4. What are the implications of a final dividend recommendation?
   • A final dividend recommendation indicates the company’s profitability and willingness to distribute profits to shareholders, thereby enhancing shareholder value.
5. How are regulatory disclosures beneficial for investors?
   • Regulatory disclosures ensure transparency and accountability, enabling investors to make informed decisions and evaluate the company’s governance practices.

also read: Epigral Limited

---